Nabriva Therapeutics plc Human Resources Contracts & Agreements
39 Contracts & Agreements
- Bonus & Incentive Agreements (13 contracts)
- Consulting Agreements (7)
- Employment Agreements (11)
- Retention Agreements (1)
- Separation Agreements (7)
- Consulting Agreement, by and between Nabriva Therapeutics US, Inc. and J. Christopher Naftzger (Filed With SEC on July 7, 2023)
- Consulting Agreement, by and between Nabriva Therapeutics US, Inc. and Daniel Dolan (Filed With SEC on July 7, 2023)
- Separation and Release of Claims Agreement, by and between Nabriva Therapeutics US, Inc. and J. Christopher Naftzger (Filed With SEC on July 7, 2023)
- Separation and Release of Claims Agreement, by and between Nabriva Therapeutics US, Inc. and Daniel Dolan (Filed With SEC on July 7, 2023)
- Consulting Agreement, by and between Nabriva Therapeutics US, Inc. and Christine Guico-Pabia (Filed With SEC on April 17, 2023)
- Separation and Release of Claims Agreement, by and between Nabriva Therapeutics US, Inc. and Christine Guico-Pabia (Filed With SEC on April 17, 2023)
- Consulting Agreement, by and between Nabriva Therapeutics US, Inc. and Steven Gelone (Filed With SEC on January 20, 2023)
- Consulting Agreement, by and between Nabriva Therapeutics US, Inc. and Theodore Schroeder (Filed With SEC on January 20, 2023)
- Separation and Release of Claims Agreement, by and between Nabriva Therapeutics US, Inc. and Steven Gelone (Filed With SEC on January 20, 2023)
- Separation and Release of Claims Agreement, by and between Nabriva Therapeutics US, Inc. and Theodore Schroeder (Filed With SEC on January 20, 2023)
- Form of Contingent RSU Award Agreement under the 2020 Share Incentive Plan, as amended (Filed With SEC on March 29, 2022)
- Employment Agreement dated August 23, 2021 by and between Nabriva Therapeutics US, Inc. and Christine Guico-Pabia (Filed With SEC on November 9, 2021)
- Employment Agreement dated August 24, 2021 by and between Nabriva Therapeutics US, Inc. and J. Christopher Naftzger (Filed With SEC on November 9, 2021)
- 2021 Inducement Share Incentive Plan, as amended (Filed With SEC on October 8, 2021)
- Form of Share Option Agreement under the 2021 Inducement Share Incentive Plan (Filed With SEC on May 6, 2021)
- Form of Restricted Share Unit Agreement under the 2020 Share Incentive Plan, as amended (Automatic Sale) (Filed With SEC on May 6, 2021)
- Form of Restricted Share Unit Agreement under the 2020 Share Incentive Plan, as amended (Share Withholding) (Filed With SEC on May 6, 2021)
- Form of Share Option Agreement under the 2020 Share Incentive Plan, as amended (Filed With SEC on May 6, 2021)
- Consulting Agreement, dated May 3, 2021, by and between Nabriva Therapeutics US, Inc. and Jennifer Schranz (Filed With SEC on May 6, 2021)
- Consulting Agreement, by and between Nabriva Therapeutics US, Inc. and Sender Consulting LLC, dated as of March 9, 2021 (Filed With SEC on March 11, 2021)
- Employment Agreement, by and between Nabriva Therapeutics US, Inc. and Daniel Dolan, dated as of March 10, 2021 (Filed With SEC on March 11, 2021)
- 2021 Inducement Share Incentive Plan (Filed With SEC on March 11, 2021)
- Third Amended and Restated Employment Agreement by and between Nabriva Therapeutics US, Inc. and Steven Gelone, dated as of March 10, 2021 (Filed With SEC on March 11, 2021)
- Amended and Restated Employment Agreement, by and between Nabriva Therapeutics US, Inc. and Theodore Schroeder, dated as of March 10, 2021 (Filed With SEC on March 11, 2021)
- Amended and Restated Employment Agreement, by and between Nabriva Therapeutics US, Inc. and Robert Crotty, dated as of March 10, 2021 (Filed With SEC on March 11, 2021)
- Retention Agreement, dated August 5, 2020, by and between Nabriva Therapeutics US, Inc. and Jennifer Schranz (Filed With SEC on November 5, 2020)
- Form of Share Option / Cash Settled Share Appreciation Right Agreement under the 2020 Share Incentive Plan (Filed With SEC on March 12, 2020)
- 2020 Share Incentive Plan (Filed With SEC on March 12, 2020)
- Form of Restricted Share Unit Agreement under the 2017 Share Incentive Plan (Share Withholding) (Filed With SEC on March 12, 2020)
- Employment Agreement, by and between Nabriva Therapeutics US, Inc. and Jennifer Schranz, dated as of March 21, 2018 (Filed With SEC on March 12, 2019)
- Second Amended and Restated Employment Agreement by and between Nabriva Therapeutics US, Inc. and Steven Gelone, dated as of July 24, 2018 (Filed With SEC on November 6, 2018)
- Employment Agreement, by and between Nabriva Therapeutics US, Inc. and Theodore Schroeder, dated as of July 23, 2018 (Filed With SEC on July 25, 2018)
- Transition, Separation and Release of Claims Agreement, by and between Nabriva Therapeutics US, Inc. and Colin Broom, dated as of July 23, 2018 (Filed With SEC on July 25, 2018)
- Form of Share Option Agreement under the 2017 Share Incentive Plan (Filed With SEC on February 2, 2018)
- Form of Restricted Share Unit Agreement under the 2017 Share Incentive Plan (Filed With SEC on February 2, 2018)
- 2017 Share Incentive Plan (Filed With SEC on November 9, 2017)
- SEPARATION AND RELEASE OF CLAIMS AGREEMENT (Filed With SEC on August 31, 2017)
- EMPLOYMENT AGREEMENT (Filed With SEC on August 7, 2017)
- EMPLOYMENT AGREEMENT (Filed With SEC on August 7, 2017)
